Skip to main content
2025 ACVS Surgery Summit Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Program Icons
Additional Fee
Additional Fee
By Invitation Only
By Invitation Only
Hybrid Laboratory
Hybrid Laboratory
Preregistration Recommended
Preregistration Recommended
Recorded for On-Demand
Recorded for On-Demand
Working Group
Working Group
Eligible for ACVS MOC
Eligible for ACVS MOC

John Peroni, DVM, MS, DACVS (Large Animal) (he/him/his)

Professor of Surgery
University of Georgia
ATHENS, Georgia

Dr. Peroni graduated from the College of Veterinary Medical Science at the University of Parma in Italy in 1994. During Veterinary School traveled to the U.S. and attended several institutions for prolonged periods of time including Delaware Equine Center, the University of Pennsylvania at New Bolton Center, Davis College of Veterinary Medicine and Chino Valley Equine Hospital. As a result of those experiences, he was encouraged to pursue an internship at Chino Valley Equine Hospital where he remained for 2 years from ’94 to ‘96. He subsequently moved to Michigan State University where he completed a surgical residency and a MS degree from 1996 to 2000. Following this training he was fortunate to become a faculty member at the University of Georgia in the Fall of 2000 and is currently an Associate Professor with clinical, didactic and research responsibilities. Dr. Peroni’s research interests began with and still include the area of equine laminitis. The main focus of this interest has been the understanding of microvascular flow within the equine hoof capsule and the changes that occur to blood flow during the onset of laminitis. In the last 7 years, however, his research interest has shifted toward the development of animal models for the implementation of regenerative therapies aimed at the repair of musculoskeletal disorders primarily fracture repair. Two additional areas that have occupied much of his recent interest and efforts have been the study of (i) the anti-inflammatory and immunomodulatory effects of mesenchymal stem cells and (ii) the interaction between delivered cellular therapies and the host environment.

Disclosure information not submitted.

Presentation(s):